FF Pharmaceuticals – Exit
FF Pharmaceuticals focuses on the development of novel disease-modifying therapeutics for the treatment of inflammatory diseases
| Sector: | Antibody therapeutics |
| Country: | The Netherlands / Belgium |
| Status: | Written off |
Vesalius Biocapital offers venture capital
to young European innovative life science companies